With Eli Lilly's recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced plans to present new research from ...

Scientists think those cholesterol-lowering statins might be doing something else we didn't know about: protecting our brains ...

Cardiologists often struggle to assess heart attack risk. New startups using AI could help.

As developers of gene editing therapies and other genetic medicines get set to report third quarter earnings in coming days, analysts and especially investors will keep their eyes on whether the ...

An updated guideline on the management of dyslipidemias has been published by the European Society of Cardiology and European Atherosclerosis Society.

Researchers have developed a DNA-based therapy that targets the PCSK9 gene to lower cholesterol naturally. Using polypurine ...

The 2025 edition of the European Society for Medical Oncology(ESMO) was held this week in Berlin, delve into its key ...